Levy, Antonin <br/><br/>
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  Mar 2015 
 - 415-6 p.  digital 
<br/><br/> Publication Type: Letter; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2015.02.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Anus Neoplasms--radiotherapy<br/>Cetuximab<br/>Chemoradiotherapy<br/>Clinical Trials, Phase II as Topic<br/>Humans